Regulation of penicillin-binding protein activity: description of a methicillin-inducible penicillin-binding protein

Insights

Methicillin-resistant Staphylococcus aureus strains R1 and R2 exhibit altered penicillin-binding proteins (PBPs). Strain R2 develops novel PBP-2a, while R1 increases PBP-3, both showing low methicillin affinity.

Area of Science:

  • Microbiology
  • Molecular Biology
  • Biochemistry

Background:

  • Methicillin-resistant Staphylococcus aureus (MRSA) poses a significant public health threat.
  • Understanding the molecular mechanisms of beta-lactam resistance in MRSA is crucial for developing effective treatments.

Purpose of the Study:

  • To analyze the penicillin-binding protein (PBP) profiles of two distinct MRSA strains (R1 and R2).
  • To investigate how methicillin exposure affects PBP expression and characteristics in these strains.
  • To correlate PBP alterations with methicillin resistance levels.

Main Methods:

  • Analysis of penicillin-binding proteins (PBPs) in MRSA strains R1 and R2.
  • Comparison of PBP patterns in cells grown with and without methicillin.
  • Determination of PBP affinity for methicillin and correlation with Minimum Inhibitory Concentrations (MICs).

Main Results:

  • Strain R2, under methicillin pressure, uniquely synthesized a novel PBP (PBP-2a) with low methicillin affinity.
  • Strain R1, under methicillin pressure, showed increased production of PBP-3, also exhibiting low methicillin affinity.
  • These PBP alterations in both strains correlated with their observed methicillin resistance (MICs).

Conclusions:

  • Specific alterations in penicillin-binding proteins (PBPs), such as the emergence of PBP-2a in strain R2 and increased PBP-3 in strain R1, are key mechanisms conferring methicillin resistance in Staphylococcus aureus.
  • The low affinity of these altered PBPs for methicillin explains the resistance phenotype observed in these MRSA strains.

Related Concept Videos

Prokaryotic Transcriptional Activators and Repressors01:58

Prokaryotic Transcriptional Activators and Repressors

The organization of prokaryotic genes in their genome is notably different from that of eukaryotes. Prokaryotic genes are organized, such that the genes for proteins involved in the same biochemical process or function are located together in groups. This group of genes, along with their regulatory elements, are collectively known as an operon. The functional genes in an operon are transcribed together to give a single strand of mRNA known as polycistronic mRNA.
Transcription of prokaryotic...
Production of Antibiotics01:27

Production of Antibiotics

Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...
Regulation of Bacterial Virulence01:28

Regulation of Bacterial Virulence

Pathogenic bacteria employ a range of regulatory mechanisms to modulate the expression of virulence genes in response to environmental and host-derived signals. These mechanisms ensure that virulence factors are expressed only under favorable conditions, thereby optimizing infection and survival strategies.Mechanisms of Virulence RegulationKey regulatory strategies include:Two-Component Systems: These consist of a membrane-bound sensor kinase and a cytoplasmic response regulator. Environmental...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...